Prophylactic non-steroidal anti-inflammatory agents for the prevention of cystoid macular oedema after cataract surgery
Authors:
- 15 June 2011
- reference entry
- Published by Wiley
- No. 6
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Effects of Intrathecal Ketorolac on Human Experimental PainAnesthesiology, 2010
- Complications ophtalmologiques des immunosuppresseurs et des corticoïdesTherapies, 2010
- Cystoid Macular Edema2009
- Cystoid Macular Edema: Current Modes of TherapyInternational Ophthalmology Clinics, 2005
- Visual outcomes after vitreous loss during cataract surgery performed by residentsJournal of Cataract & Refractive Surgery, 2002
- Ischaemic heart disease may predispose to pseudophakic cystoid macular oedemaEye, 2001
- Ocular complications of topical, peri-ocular, and systemic corticosteroidsCurrent Opinion in Ophthalmology, 2000
- Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery:American Journal of Ophthalmology, 1999
- The Quantitative Effect of 0.5% Ketorolac Tromethamine Solution and 0.1% Dexamethasone Sodium Phosphate Solution on Postsurgical Blood-Aqueous BarrierArchives of Ophthalmology (1950), 1988
- Effectiveness of Ketorolac Tromethamine 0.5% Ophthalmic Solution for Chronic Aphakic and Pseudophakic Cystoid Macular EdemaAmerican Journal of Ophthalmology, 1987